INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 74 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,000 | -51.0% | 10,460 | -42.5% | 0.00% | -100.0% |
| Q3 2018 | $49,000 | -82.9% | 18,200 | -90.1% | 0.00% | -66.7% |
| Q2 2017 | $287,000 | +567.4% | 183,000 | +468.8% | 0.00% | – |
| Q4 2016 | $43,000 | -88.3% | 32,171 | -4.0% | 0.00% | -100.0% |
| Q2 2015 | $367,000 | -24.8% | 33,500 | -4.1% | 0.01% | -50.0% |
| Q1 2015 | $488,000 | +185.4% | 34,946 | +246.0% | 0.01% | +100.0% |
| Q4 2014 | $171,000 | – | 10,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |